Background: Prior data suggests that breast cancer screening rates are lower among women in the Appalachian region of the United States. This study examined the changes in breast cancer screening before and after the implementation of the Affordable Care Act Medicaid expansion, in Appalachia and non-Appalachia states. Results: The prevalence for of self-reported breast cancer screening in Appalachia and non-Appalachia states were 83% and 82% (P < .001), respectively. In Appalachian states, breast cancer screening was marginally higher in non-expanded versus expanded states in both the pre-expansion (relative risk [RR]: 1.002, 95% confidence interval [CI]: 1.002-1.003) and post-expansion period (RR: 1.001, 95% CI: 1.001-1.002). In non-Appalachian states, screening was lower in non-expanded states versus expanded states in both the pre-expansion (RR: 0.98, 95% CI: 0.97-0.98) and post-expansion period (RR: 0.95, 95% CI: 0.95-0.96). There were modest 3% to 4% declines in breast cancer screening rates in the pos-texpansion period regardless of expansion and Appalachia status.
Introduction
Breast cancer is the most commonly diagnosed cancer among women in the United States, with an estimated 252 710 new breast cancer cases and 40 610 deaths expected in 2017. 1 Progress in early detection through mammography and improvements in breast cancer treatment have markedly improved the prognosis for breast cancer, and death rates are now about onethird of the levels in 1990. [2] [3] [4] However, these benefits are not distributed equally across the US population. 1 Evidence suggests that Appalachian women experience 7% higher breast cancer mortality compared with non-Appalachian women in the United States, partly due to the higher likelihood of breast cancer being diagnosed at a late stage. 5, 6 The Appalachian geographic region represents 8% of the US population, an area consisting of 420 contiguous counties spanning 13 states. The National Cancer Institute recognizes the Appalachia region of the United States as a special priority area, given that it represents one of the most economically disadvantaged, and medically underserved regions in the United States. [7] [8] [9] [10] Several factors have been identified that may explain later stage at diagnosis and higher breast cancer mortality observed among women living in the Appalachian regions of the United States, [11] [12] [13] including lower socioeconomic status and lack of access to health care, 9, 14, 15 lower prevalence of routine mammography, and a lower likelihood to receive recommended treatment for breast cancer. [16] [17] [18] In 2010, the Patient Protection and Affordable Care Act (ACA) was passed by the US Congress to increase health insurance coverage and expand access to health-care services for Americans. In 2014, approximately 64% of the US population was covered through private insurance, 19 and this proportion has increased with 6.7 million people newly enrolled in 2014 via the insurance marketplace established under the ACA. 20 Although as part of the ACA, states have the option of expanding Medicaid to increase health insurance coverage among low-income and uninsured individuals, participation in the Medicaid expansion provision of the ACA occurred in varying degrees across states. [21] [22] [23] [24] To date, 31 states including the District of Columbia have expanded Medicaid to low-income adults (individuals with an annual household income <138% of the federal poverty level) or individuals with qualifying disabilities. [25] [26] [27] In addition to increasing health insurance coverage, ACA also required most health plans to cover preventive health-care serveries without copays or deductibles for A or Brated recommendations by the US Preventive Services Task Force (USPSTF). In November 2009, the USPSTF issued new age-based recommendations for mammography screening, recommending routine mammography every 2 years for women ages 50 to 74 years. 28 Although the ACA and Medicaid expansion has substantially increased health insurance coverage and improved access to health-care services for previously uninsured and lowincome Americans, 24 the specific impact of the policy on breast cancer screening is still unclear. 29 According to a recent review of the literature, 29 the lack of consistency in published estimates may be due to limited number of existing studies, methodological limitations, and the fact that most studies examined only a short time period post-ACA. Despite the higher proportion of uninsured and low-income women in Appalachia regions of the United States, few studies have directly evaluated the impact of the ACA Medicaid expansion on breast cancer screening behaviors in this region relative to other parts of the US. [11] [12] [13] The current study aims to examine changes in breast cancer screening before and after ACA Medicaid expansion comparing Appalachia and non-Appalachia states. Results may highlight the impact of health insurance changes due to the ACA on breast cancer screening rates in a historically under-served region, and highlight areas where additional strategies may be needed to narrow existing health disparities.
Methods

Data Source
Data were obtained from the Centers for Disease Control and Prevention (CDC) Behavioral Risk Factor Surveillance System (BRFSS). The BRFSS is a representative ongoing, state-based system of landline-and cellular-telephone health surveys. 30, 31 The BRFSS uses a multistage sampling design to obtain data on self-reported health-related information from non-institutionalized civilian population aged !18 years residing in all 50 states, including the District of Columbia and the 3 US territories (Guam, Puerto Rico, and the US Virgin Islands). 30 The BRFSS collected data on demographic characteristics, health-related behaviors, chronic health conditions, health-care access, and the use of preventive health services that are associated with the leading causes of death and disability in the United States. 30, 31 Each year of the BRFSS surveys includes 3 parts: (1) the core component, (2) optional modules, and (3) state-added questions. Since 2000, questions regarding women's health, including history of mammography visits, were asked in even years in all states as part of the BRFSS fixed core questionnaire.
The current study utilizes data for the years 2003 through 2015, and analysis was performed in 2017. As the BRFSS database is a publicly available and deidentified data source, this study was considered exempt by the institutional review board at the University of Kentucky.
Study Variables
Outcome. The primary outcome in this study was self-reported mammography screening received in the past 2 years. According to USPSTF recommendations, women aged 50 to 74 years are considered up-to-date if they reported receipt of a mammogram in the previous 2 years. 28 Respondents who refused to answer, had a missing response, or answered "don't know/not sure" were excluded from the analyses. Study covariates. These included income level (categorized as <$10 000, $10 000-$20 000, $20 000-$50 000, and !$50 000), respondents' age (categorized as 50-59, 60-69, and 70-74 years), race/ethnicity (white, black, Hispanic, other race), education level (<high school, high school graduate, some college, or !college), marital status (married, divorced/ widowed/separated, and never married/member of an unmarried couple), and employment status (employed/self-employed, out of work, homemaker, student, retired, or unable to work). Additionally, having a usual health-care provider (at least one provider vs no provider) and having health-care coverage (yes or no) were included. Health coverage includes private insurance, prepaid, and government plans.
Statistical Analysis
Descriptive analyses were conducted using w 2 tests to compare sociodemographic, socioeconomic, and health-care variables by Appalachia status over the study period. Due to the implementation of the ACA Medicaid expansion in 2010, calendar year 2010 was considered as the washout period. To determine whether there were differences in mammography screening between expanded and nonexpanded states across the study periods, multivariable logistic regression models with generalized estimating equations were used to interpret odds ratios as relative risks after adjusting for age-group, race/ethnicity, annual household income, education, and employment. Subgroup analysis for age groups and among women with annual household income $20 000 was also conducted. Analyses were weighted using appropriate survey procedures to account for the complex sample survey design. Results were presented as risk ratios and 95% confidence intervals (CIs), and P values of <.05 were considered statistically significant. All analyses were conducted using SAS 9.4 (SAS Institute, Cary, North Carolina).
Results
A total of 1 112 972 female participants were included in this analysis: 808 700 (73%) in non-Appalachia states and 304 272 (27%) in Appalachia states (Table 1) . Table 1 shows the baseline characteristics of the study participants overall and by Appalachia status. Overall, the majority of participants were white (82%), about 60% had some college degree or higher, 39% had an annual household income of greater than $50 000, and 91% had health insurance coverage. Compared to the nonAppalachia states, participants in Appalachia states were more likely to be black (16% vs 6%), have less than a high school education (12% vs 8%), have an average annual household income of <$10 000 (8% vs 6%), and more likely to have no health insurance coverage (9% vs 8%). Table 2 presents the prevalence of mammography screening in the past two years by socio-demographic, socio-economic and healthcare access variables.
Overall, 82% of study participants had received a mammogram in the past 2 years, 83% in Appalachia states and 82% in non-Appalachia states. In non-Appalachia states, mammography screening was higher in expanded (84%) versus nonexpanded (81%) states overall, regardless of sociodemographic characteristics. For instance, among women ages 50 to 59, screening prevalence was 83% in expanded states compared with 79% in nonexpanded states. In addition, screening was higher among whites (84% vs 81%), and Hispanics (84% vs 79%) in expanded versus nonexpanded states. Screening was lowest among women with no regular health-care provider in both expanded (55%) and non-expanded (54%) nonAppalachia states and highest among those with annual household income >$50 000. In Appalachia states, there were only modest differences in screening prevalence between expanded and non-expanded states. For instance, 82% of women ages 50 to 59 years were screened in expanded Appalachian states, compared with 83% in non-expanded Appalachian states. Similar to non-Appalachia states, screening was highest among women with annual household income >$50 000 and lowest among women with no regular health-care provider.
As shown in Table 3 In non-Appalachia states, screening was lower in nonexpanded states versus expanded states in pre-expansion (RR: 0.978, 95% CI: 0.978-0.979) and postexpansion periods (RR: 0.958, 95% CI: 0.955-0.959). Stronger associations were observed in the 50-59 years and 60-69 years age groups (Table 3) . Among expanded states, there was 5% lower screening (RR: 0.956, 95% CI: 0.949-0.957) in the post versus pre-expansion period, while non-expanded states had 3% lower screening (RR: 0.970, 95% CI: 0.969-0.978) in the post-expansion versus pre-expansion period (Table 4) .
In subgroup analysis by age group and household income $20 000 (Table 4) , there was a 3% decline in screening post-versus pre-expansion (RR: 0.972, 95% CI: 0.969-0.973) in Appalachia, and in non-Appalachia, there was a 5% (RR: 0.956, 95% CI: 0.949-0.957) and 3% (RR: 0.978, 95% CI: 0.969-0.978) decline post-versus pre-expansion in expanded states and nonexpanded states, respectively. Similar declines were observed among low-income participants (annual household income $20 000).
Discussion
In a large nationally representative study population of women aged 50-74 years in Appalachia and non-Appalachia US states, this study examined the impact of ACA Medicaid expansion on breast cancer screening pre-and post-expansion. Results showed that 83% of women in Appalachia states selfreported breast cancer screening in the past 2 years, compared with 82% of women in non-Appalachia states. Overall in Appalachia states, there were negligible differences in screening prevalence comparing expanded and non-expanded states; however, in non-Appalachia states, screening prevalence was significantly higher in expanded compared with non-expanded states. In adjusted models, screening in Appalachia states was marginally higher in non-expanded states compared with expanded states in both pre-and post-expansion periods. However, within expanded and non-expanded Appalachia states, screening declined in the post-versus pre-expansion period. In non-Appalachia states, screening was lower in non-expanded states compared with expanded states in both pre-and post-expansion periods, and within expanded and non-expanded states, screening declined in the post-expansion period compared with pre-expansion period. Previous studies have examined the impact of Medicaid expansion on self-reported breast cancer screening among US adults. 3, 26, [33] [34] [35] [36] [37] [38] [39] [40] Similar to our findings, other studies have observed significant reductions in breast cancer screening in the post-expansion period. 26, [34] [35] [36] 39 Two US studies 26, 36 found a 13% 26 and 20% 36 reduced odds of breast cancer screening in the post-expansion period among women aged 50 to 74 years. We observed that in non-expanded Appalachia states, women aged 50 to 59 years had marginally higher screening in both the pre-and post-expansion periods. However, among women aged 60 to 69 years, screening was marginally higher in the pre-expansion compared to the post-expansion period, but was marginally higher among women aged 70 to 74 years higher in the postexpansion compared to the pre-expansion period.
In non-expanded non-Appalachia states, screening was lower across all the age groups consistently in the post-expansion compared to the pre-expansion period. In the preexpansion period, screening was lowest among women aged 37 Two cross-sectional studies using the BRFSS found higher prevalence of selfreported mammography in the expanded states of 5% 33 and 3% 40 in 2012 and 2014, respectively, and a separate study observed that among low-income women, screening rates were 8% higher in expanded states compared to nonexpanded states. 40 Our study adds more recent, empirical data regarding the impact of Medicaid expansion on breast cancer screening in the United States and reveals that, in general, there were declines in breast cancer screening in the post-ACA period in both expanded and non-expanded states, regardless of Appalachia status. There are several possible reasons for these observations, including state-level differences in Medicaid expansion eligibility and requirements, lack of information regarding insurance benefits, confusion about changing guidelines regarding appropriate timing and frequency of screening, or lack of health-care provider recommendation.
First, we observed the lowest breast cancer screening prevalence among women with no regular health-care provider (55% in expanded non-Appalachia states; 54% in non- expanded non-Appalachia states, 54% in expanded Appalachia states; and 59% in non-expanded Appalachia states), suggesting that lack of provider recommendation remains a strong predictor of routine screening regardless of expansion or Appalachia status, as shown in previous studies. [41] [42] [43] [44] Second, while the ACA aimed to provide free or reduced cost coverage for screening services that were previously not available and/or affordable, some studies have reported significant administrative barriers that reduced utilization of this benefit, such as outof-network fees or restrictions on grandfathered plans. 34 In addition, insurance coverage through the ACA may not necessarily guarantee receipt of those services. 45 States were given latitude to establish their own Medicaid eligibility requirements and reimbursements, and given significant variation in eligibility and administrative requirements across states in Medicaid programs, [21] [22] [23] [24] utilization of the benefit for preventive care, including breast cancer screening, may be negatively affected. Further, according to the Kaiser Family Foundation, awareness of the provisions of the ACA policy remains low; in a 2014 poll, only 43% of Americans were aware of the free preventive health-care benefits available as part of the ACA. 20 Third, a recent study observed that despite the availability of screening services, most of the women in the target population are not screened due to lack of knowledge of screening guidelines or transportation issues and lack of providers in proximity, 46 suggesting that lack of access to health care, independent of insurance status, remains a significant barrier to breast cancer screening. Future studies are needed to better target these disparate populations and address barriers to health-care access. Fourth, while self-reported measures of women's cancer screening in the BRFSS have been validated 47, 48 as we and others have shown that [34] [35] [36] [37] 39 self-reported measures of breast cancer screening are subject to recall bias 49 resulting in misclassification, with a significant proportion of participants overreporting screening practices. Data using objective measures of screening from claims data across Medicaid expansion and Appalachia states may be necessary to definitively estimate the impact of the ACA on breast cancer screening in the United States.
There were certain limitations relevant to this study. First, given that breast cancer screening information in the BRFSS are only assessed in the BRFSS in even years, we were able to analyze only 2 years of data for 2012 and 2014 in the ACA Medicaid post-expansion period, which may be too short to fully capture the influence of ACA expansion on screening. Future studies based on a longer follow-up period from ACA expansion will help to further clarify these findings. Also, we were unable to assess screening among respondents based on the type of insurance, duration of the insurance, and also if the type of insurance was adequate to cover screening services. The BRFSS asked whether respondents have insurance but not type of coverage (Medicaid, Medicare, or private); therefore, we were unable to compare differences based on insurance types. Second, in 2010, the BRFSS introduces a new weighting method, which replaced the poststratification method with raking (iterative proportional fitting). 50 According to the CDC, comparison between years before and after these changes may have been affected. 50 We examined the trends in the preexpansion period (2003) (2004) (2005) (2006) (2007) (2008) (2009) ) and postexpansion periods (2011) (2012) (2013) (2014) (2015) by categorizing expanded and nonexpanded states and examining the trends while considering calendar year 2010 as our washout period. Another methodological change in 2011 was the addition of cell phone numbers along with landline telephones numbers to administer the BRFSS survey, while prior surveys utilized landline telephone numbers exclusively. Third, evaluation of the impact of the ACA Medicaid expansion policy on breast cancer screening may be vulnerable to ecological bias; however, this approach is used extensively to assess state-wide health policies, and we utilized statistically rigorous approaches to our analysis, including comparing preand postexpansion screening rates among expanded and nonexpanded states and utilizing multivariable adjusted regression models to account for study covariates.
This study addresses several of the gaps in previous literature on this topic. Specifically, we compared expansion status based on Appalachia status. Prior studies have shown that women in Appalachia regions have much lower breast cancer screening rates and significantly higher mortality rates compared to the national average, 11, 16 although none of the prior studies have evaluated the role of ACA expansion in this region. Second, the analysis evaluated differences in screening rates by pre-and post-expansion status. Other studies have only evaluated differences in screening postexpansion only, without accounting for baseline screening levels. 26, 40 Also, our analyses include a large sample size, racial and socioeconomically diverse study population, and a nationally representative source of data that enhances generalizability, while the use of standardized interview questions across all the survey years that enhances the reliability of our main study measure.
In summary, breast cancer screening rates were higher in Appalachia versus non-Appalachia US states, and higher in expanded versus nonexpanded non-Appalachia states. There were also modest declines in breast cancer screening rates in the post-expansion period regardless of expansion and Appalachia status, suggesting that more work is needed to reduce administrative, logistical, and structural barriers to breast cancer screening services for US women.
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